What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
His primary areas of study are Immunology, Allele, Asthma, Genetics and Internal medicine.
His study looks at the relationship between Immunology and topics such as Promoter, which overlap with Immunoglobulin E.
His Allele research includes themes of Odds ratio, Sarcoidosis, Systemic disease and Genotype.
His biological study spans a wide range of topics, including SNP, Single-nucleotide polymorphism and COPD.
Nobuyuki Hizawa interconnects Endocrinology and Oncology in the investigation of issues within Internal medicine.
His work deals with themes such as Pulmonary alveolar proteinosis, Surgery and Intensive care, which intersect with Respiratory disease.
His most cited work include:
- Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer (302 citations)
- Characteristics of a Large Cohort of Patients with Autoimmune Pulmonary Alveolar Proteinosis in Japan (254 citations)
- Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population (248 citations)
What are the main themes of his work throughout his whole career to date?
Immunology, Internal medicine, Asthma, Lung cancer and Pathology are his primary areas of study.
The study incorporates disciplines such as Single-nucleotide polymorphism and Gene, Allele in addition to Immunology.
His study explores the link between Internal medicine and topics such as Oncology that cross with problems in Epidermal growth factor receptor.
While the research belongs to areas of Asthma, Nobuyuki Hizawa spends his time largely on the problem of COPD, intersecting his research to questions surrounding Disease.
His Lung cancer research incorporates elements of Cancer, Carcinoma and Surgery.
In his study, Adenocarcinoma is inextricably linked to Lung, which falls within the broad field of Pathology.
He most often published in these fields:
- Immunology (38.07%)
- Internal medicine (29.55%)
- Asthma (24.72%)
What were the highlights of his more recent work (between 2018-2021)?
- Immunology (38.07%)
- Asthma (24.72%)
- Internal medicine (29.55%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Immunology, Asthma, Internal medicine, Lung cancer and Oncology.
Nobuyuki Hizawa combines subjects such as Genome-wide association study and Late onset with his study of Immunology.
His Asthma research incorporates themes from Phenotype, COPD, Genotype and Expression quantitative trait loci.
His work is dedicated to discovering how Genotype, Serum ige are connected with Locus and other disciplines.
His study in Lung cancer is interdisciplinary in nature, drawing from both Gastroenterology, Disease, Epidermal growth factor receptor and Lymph.
His Oncology research is multidisciplinary, incorporating perspectives in Incidence, Metastasis, Retrospective cohort study and Adenocarcinoma.
Between 2018 and 2021, his most popular works were:
- A genetic variant near TSLP is associated with chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory disease in Japanese populations (5 citations)
- Pasteurella multocida pneumonia with hemoptysis: A case report. (5 citations)
- Identification of whole blood gene expressions correlated with responsiveness to benralizumab (3 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
His scientific interests lie mostly in Immunology, Asthma, Internal medicine, Atopy and Lung.
His work carried out in the field of Immunology brings together such families of science as Genetic variants, Aspirin and Aspirin exacerbated respiratory disease.
His research in Asthma intersects with topics in Allergic sensitization, Expression quantitative trait loci and Genotype.
His Atopy study deals with Genome-wide association study intersecting with Odds ratio, Late onset, Endotype, CHI3L1 and Cohort.
His Lung research includes elements of Macrophage and Environmental exposure.
His Non small cell study in the realm of Lung cancer connects with subjects such as Food and drug administration.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
